CDNA
Price
$12.79
Change
-$0.05 (-0.39%)
Updated
Jul 25 closing price
Capitalization
548.33M
11 days until earnings call
SNNUF
Price
$14.94
Change
+$0.19 (+1.29%)
Updated
Jul 24 closing price
Capitalization
13.3B
Interact to see
Advertisement

CDNA vs SNNUF

Header iconCDNA vs SNNUF Comparison
Open Charts CDNA vs SNNUFBanner chart's image
CareDx
Price$12.79
Change-$0.05 (-0.39%)
Volume$877.59K
Capitalization548.33M
Smith & Nephew
Price$14.94
Change+$0.19 (+1.29%)
Volume$7.62K
Capitalization13.3B
CDNA vs SNNUF Comparison Chart in %
Loading...
CDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNNUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDNA vs. SNNUF commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDNA is a Hold and SNNUF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (CDNA: $12.79 vs. SNNUF: $14.94)
Brand notoriety: CDNA and SNNUF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CDNA: 58% vs. SNNUF: 249%
Market capitalization -- CDNA: $548.33M vs. SNNUF: $13.3B
CDNA [@Medical Specialties] is valued at $548.33M. SNNUF’s [@Medical Specialties] market capitalization is $13.3B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDNA’s FA Score shows that 0 FA rating(s) are green whileSNNUF’s FA Score has 1 green FA rating(s).

  • CDNA’s FA Score: 0 green, 5 red.
  • SNNUF’s FA Score: 1 green, 4 red.
According to our system of comparison, SNNUF is a better buy in the long-term than CDNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDNA’s TA Score shows that 5 TA indicator(s) are bullish while SNNUF’s TA Score has 4 bullish TA indicator(s).

  • CDNA’s TA Score: 5 bullish, 5 bearish.
  • SNNUF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SNNUF is a better buy in the short-term than CDNA.

Price Growth

CDNA (@Medical Specialties) experienced а +7.34% price change this week, while SNNUF (@Medical Specialties) price change was +1.29% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was +5.16%, and the average quarterly price growth was -1.87%.

Reported Earning Dates

CDNA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNNUF($13.3B) has a higher market cap than CDNA($548M). SNNUF YTD gains are higher at: 18.808 vs. CDNA (-40.262). SNNUF has higher annual earnings (EBITDA): 874M vs. CDNA (-84.92M). SNNUF has more cash in the bank: 516M vs. CDNA (235M). CDNA has less debt than SNNUF: CDNA (34.2M) vs SNNUF (2.89B). SNNUF has higher revenues than CDNA: SNNUF (5.22B) vs CDNA (280M).
CDNASNNUFCDNA / SNNUF
Capitalization548M13.3B4%
EBITDA-84.92M874M-10%
Gain YTD-40.26218.808-214%
P/E RatioN/A58.48-
Revenue280M5.22B5%
Total Cash235M516M46%
Total Debt34.2M2.89B1%
FUNDAMENTALS RATINGS
CDNA vs SNNUF: Fundamental Ratings
CDNA
SNNUF
OUTLOOK RATING
1..100
633
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
6
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4694
PRICE GROWTH RATING
1..100
9448
P/E GROWTH RATING
1..100
9489
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNNUF's Valuation (6) in the null industry is significantly better than the same rating for CDNA (96) in the Medical Specialties industry. This means that SNNUF’s stock grew significantly faster than CDNA’s over the last 12 months.

SNNUF's Profit vs Risk Rating (100) in the null industry is in the same range as CDNA (100) in the Medical Specialties industry. This means that SNNUF’s stock grew similarly to CDNA’s over the last 12 months.

CDNA's SMR Rating (46) in the Medical Specialties industry is somewhat better than the same rating for SNNUF (94) in the null industry. This means that CDNA’s stock grew somewhat faster than SNNUF’s over the last 12 months.

SNNUF's Price Growth Rating (48) in the null industry is somewhat better than the same rating for CDNA (94) in the Medical Specialties industry. This means that SNNUF’s stock grew somewhat faster than CDNA’s over the last 12 months.

SNNUF's P/E Growth Rating (89) in the null industry is in the same range as CDNA (94) in the Medical Specialties industry. This means that SNNUF’s stock grew similarly to CDNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDNASNNUF
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
60%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
49%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
45%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
52%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
53%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
62%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
49%
View a ticker or compare two or three
Interact to see
Advertisement
CDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNNUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SN120.342.01
+1.70%
SharkNinja
PLAB19.720.12
+0.61%
Photronics
SLNHP4.03N/A
N/A
Soluna Holdings
ALTI4.38N/A
N/A
AlTi Global
LINK7.00-0.28
-3.86%
Interlink Electronics

CDNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDNA has been loosely correlated with NTRA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CDNA jumps, then NTRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDNA
1D Price
Change %
CDNA100%
-0.39%
NTRA - CDNA
42%
Loosely correlated
-1.53%
VCYT - CDNA
41%
Loosely correlated
+7.04%
BLFS - CDNA
39%
Loosely correlated
+1.44%
LMAT - CDNA
35%
Loosely correlated
+2.06%
ABT - CDNA
35%
Loosely correlated
+0.72%
More

SNNUF and

Correlation & Price change

A.I.dvisor tells us that SNNUF and CDNA have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNNUF and CDNA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNNUF
1D Price
Change %
SNNUF100%
N/A
CDNA - SNNUF
23%
Poorly correlated
-0.39%
CSTL - SNNUF
23%
Poorly correlated
-2.19%
SNN - SNNUF
22%
Poorly correlated
+0.60%
BFLY - SNNUF
22%
Poorly correlated
-5.29%
TFX - SNNUF
21%
Poorly correlated
+0.85%
More